LifeSci Communications Fierce Pharma Asia—Takeda's Anima mRNA translation pact, China digital health incubator; Daiichi's COVID-19 vaccine
Por um escritor misterioso
Descrição
Takeda penned a potentially billion-dollar deal with Anima Biotech to work on mRNA translation modulators for neurological diseases. The Japanese pharma als

Japan's Daiichi Sankyo to make mRNA vaccine pillar of business - Nikkei Asia

Press Releases - Media - Daiichi Sankyo

Anima Biotech - mRNA Lightning Platform
.png)
Sponsor Detail Template – Chinese American Biopharmaceutical Society

World's First Inhalable COVID-19 Vaccine Approved in China - COVID-19 - mobile.

Anima Biotech - Company info. interviews, news

PharmaCompass – Grow Your Pharma Business Digitally

Collection of Healthcare News and Biomedical Development — Mar. and April 2021, by Willies Wu

Anima Biotech - Company info. interviews, news

Daiichi Sankyo applies for approval of mRNA COVID vaccine The Asahi Shimbun: Breaking News, Japan News and Analysis
de
por adulto (o preço varia de acordo com o tamanho do grupo)